UTA is tucking a small acquisition into its marketing division: The company announced the acquisition of JUV Consulting, a marketing, creative services and research agency that helps clients target ...

JUV-161 was discovered using Juvena’s proprietary JuvNET platform, an AI and stem cell secretome-based drug discovery and development platform “JUV-161 is a natural, endocrine protein therapy that ...

The consultancy, which connects brands with youth culture, will become part of UTA’s Entertainment Marketing division. By Alex Weprin Senior Editor UTA is expanding its marketing division, acquiring ...

Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses getting JUV-161 into Phase I trials this year. In this Pharmaceutical Executive video interview, Hanadie Yousef, PhD, ...

Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses Juvena’s "pipeline in a product" JUV-161 and plans to broaden into other disease indications. In this Pharmaceutical Executive ...

Activewear is my go-to for stylish, comfortable clothing. I enjoy the breathability and simplicity of a pair of spandex, matching tops, or sweat suits. And for someone who hasn’t seen a gym in years, ...

JUV, which was founded by Gen Zers and has worked with clients including Google and Unilever, will be renamed Next Gen. UTA further expands into the marketing services arena with the acquisition of ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Juvena Therapeutics, a biotechnology company unlocking the potential of stem cell-secreted proteins to treat muscle and metabolic diseases including muscular ...

REDWOOD CITY, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Juvena Therapeutics, Inc. ("Juvena”), a clinical-stage biotechnology company pioneering tissue restorative biologics for chronic muscle and ...